Presentation is loading. Please wait.

Presentation is loading. Please wait.

Potentiation of P2X4R favors remyelination and ameliorates EAE

Published byJan-Erik Borgar Antonsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Potentiation of P2X4R favors remyelination and ameliorates EAE"— Presentation transcript:

1 Potentiation of P2X4R favors remyelination and ameliorates EAE
Potentiation of P2X4R favors remyelination and ameliorates EAE ALeft, neurological score of EAE (n = 5) and ivermectin (IVM)‐treated EAE mice (1 mg/kg) (n = 5 mice/group; one representative experiment of two independent experiments). Right, axon conduction latency in the corticospinal tract of control and vehicle‐ and IVM‐treated EAE mice. Symbols indicate significance versus control (*) or versus EAE (#).BEffect of IVM (3 μM)‐ on lysolecithin (LPC)‐induced demyelination in cerebellum organotypic slices, as analyzed by MBP densitometry (n = 5).CStaining for iNOS (red) and MRC1 (green) in control and differently activated microglia in the absence or presence of IVM (3 μM) (n = 3). Scale bar = 50 μm. Symbols indicate significance versus control (*) or versus anti‐inflammatory microglia (#).DqPCR quantification of pro‐inflammatory genes (Ccl2 and Nos2) and anti‐inflammatory genes (Arg1 and Mrc1) in different activated microglia in the absence or presence of IVM (3 μM) (n = 3). Symbols indicate significance versus control (*) or versus pro‐/anti‐inflammatory microglia (#).EControl, pro‐inflammatory, and anti‐inflammatory microglia endocytosis (1 h) of Alexa 488‐labeled myelin in the absence or presence of IVM (3 μM) plus ATPγS (10 μM) (n = 4). Scale bar = 40 μm. Symbols indicate significance versus control (*) or between IVM + ATPγS‐treated and non‐treated cells (#).FMyelin degradation at 6 days, expressed as fold change versus control microglia at the same chase time, in the absence and in the presence of IVM (3 μM) + ATPγS (10 μM) (n = 4).GWithdrawal threshold (grams) of mechanical stimulation by von Frey filaments applied to the mouse hind paw in non‐treated (n = 6) and IVM‐treated mice (n = 7) at specific stages of EAE progression.Data information: Data are presented as mean ± s.e.m. Statistics were performed with Mann–Whitney U‐test (neurological score), one‐way ANOVA (A, D, E, F), and Student's t‐test (B, C). */#P < 0.05, **/##P < 0.01, ***P < 0.001.Source data are available online for this figure. Alazne Zabala et al. EMBO Mol Med. 2018;emmm © as stated in the article, figure or figure legend

Download ppt "Potentiation of P2X4R favors remyelination and ameliorates EAE"

Similar presentations

Hyp mice show hypertension and increased NCC expression and phosphorylation A–ESerum intact Fgf23 concentration (A, n = 8–9, Student's t‐test, *P = 0.0001.

Hyp mice show hypertension and increased NCC expression and phosphorylation A–ESerum intact Fgf23 concentration (A, n = 8–9, Student's t‐test, *P = 
Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.

Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.
Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.

Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.
Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.

Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.
PERK activator reduces behavioral deficits and neurodegeneration in vivo PERK activator reduces behavioral deficits and neurodegeneration in vivo A–CYoung.

PERK activator reduces behavioral deficits and neurodegeneration in vivo PERK activator reduces behavioral deficits and neurodegeneration in vivo A–CYoung.
Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.

Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.
AβOs bind to and impact hypothalamic neurons Representative immunocytochemistry images of mature hypothalamic neurons in culture exposed to vehicle (Veh)

AβOs bind to and impact hypothalamic neurons Representative immunocytochemistry images of mature hypothalamic neurons in culture exposed to vehicle (Veh)
The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.

The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.
PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.

PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.
Treatment with p38γ/p38δ inhibitor shows antifungal effects in vivo

Treatment with p38γ/p38δ inhibitor shows antifungal effects in vivo
[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.

[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.
TFE3 regulates glucose homeostasis

TFE3 regulates glucose homeostasis
The absence of COL6 in PyMT mice sensitizes tumours to cisplatin treatment.A.Eleven week old FP635/PyMT and FP635/PyMT/COL6−/− mice were given cisplatin.

The absence of COL6 in PyMT mice sensitizes tumours to cisplatin treatment.A.Eleven week old FP635/PyMT and FP635/PyMT/COL6−/− mice were given cisplatin.
Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent and cycling LGR5+ CRC cells Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent.

Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent and cycling LGR5+ CRC cells Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent.
Metabolic profile of Tfe3 KO mice

Metabolic profile of Tfe3 KO mice
Preceding knockdown of FoxO3 reduces inhibitory effect of UCN‐01 on human lung fibroblast proliferation and myofibroblast transdifferentiation in response.

Preceding knockdown of FoxO3 reduces inhibitory effect of UCN‐01 on human lung fibroblast proliferation and myofibroblast transdifferentiation in response.
In vitro and in vivo validation of Clcn3 as a miR‐1a‐3p target gene and its functional contribution to tumor‐induced mechanical hypersensitivity in the.

In vitro and in vivo validation of Clcn3 as a miR‐1a‐3p target gene and its functional contribution to tumor‐induced mechanical hypersensitivity in the.
Identification of genes associated with a gain of prion susceptibility Increased susceptibilities of revertant cell clones R2, R5 and R7 after retinoic.

Identification of genes associated with a gain of prion susceptibility Increased susceptibilities of revertant cell clones R2, R5 and R7 after retinoic.
TGF‐β1 and Sema3A are downregulated in vivo by increasing VEGF doses Muscles were harvested 7 days after implantation of V Low, V Med, and V High clones.

TGF‐β1 and Sema3A are downregulated in vivo by increasing VEGF doses Muscles were harvested 7 days after implantation of V Low, V Med, and V High clones.
Increased IFNγ producing CD4+ T cells in the spleen drives the enhanced splenic IFNγ on 6 dpi during concurrent co‐infection Increased IFNγ producing CD4+

Increased IFNγ producing CD4+ T cells in the spleen drives the enhanced splenic IFNγ on 6 dpi during concurrent co‐infection Increased IFNγ producing CD4+

Similar presentations

Ads by Google